---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-096648"
form_type: "8-K"
ticker: "MIST"
cik: "0001408443"
company_name: "Milestone Pharmaceuticals Inc."
filed_at: "2024-09-04T23:59:59+00:00"
generated_at: "2026-05-31T06:25:00.308006+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Milestone Pharmaceuticals appoints Joseph Papa to Board of Directors

## Summary
- Joseph Papa, CEO of Emergent BioSolutions, appointed director effective Sept 3, 2024; over 35 years pharma experience.
- Papa will serve on Compensation Committee; receives $42,500 annual cash retainer and 80,000-share option grant.
- 2024 annual meeting results: all 7 director nominees elected; PricewaterhouseCoopers ratified as auditor.
- Board committees updated: Fischer named Compensation Chair; Papa joins Compensation Committee.
- Company advancing CARDAMYST (etripamil nasal spray) for PSVT towards potential FDA decision.

## SEC filing metadata
- accession: 0001104659-24-096648
- form_type: 8-K
- ticker: MIST
- cik: 0001408443
- company_name: Milestone Pharmaceuticals Inc.
- filed_at: 2024-09-04T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 5.07, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1408443/000110465924096648/0001104659-24-096648-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1408443/000110465924096648/tm2423263d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-096648
- JSON: https://secwatch.observer/filing/0001104659-24-096648.json
- Plain text: https://secwatch.observer/filing/0001104659-24-096648.txt

## Key facts
- Executive change
  Joeseph C. Papa was elected as member of the Board at Milestone Pharmaceuticals Inc..
  - Action: elected
  - Role: member of the Board
  source text: the Board of Directors (the “ Board ”) of Milestone Pharmaceuticals Inc. (the “ Company ”), upon the recommendation of the Nominating & Corporate Governance Committee of the Board, voted to elect Joeseph C. Papa as a member of the Board and as a member of the Board’s compensation committee (the “ Compensation Committee ”), effective as of September 3, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1408443/000110465924096648/0001104659-24-096648-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.